Articles From: Agenus to Participate in Brain Cancer Vaccine and Immunotherapy Discussion on September 23rd Webcast to AGF Offers New Funds on UCITS Platform


2013/9/18
Agenus Inc. (NASDAQ: AGEN) today announced that Dr.
Sign-up for Agenus to Participate in Brain Cancer Vaccine and Immunotherapy Discussion on September 23rd Webcast investment picks
2014/2/6
Agenus Inc. (Nasdaq: AGEN), a biotechnology company developing novel immune system activating treatments for cancers and infectious diseases, today announced that the company will be presenting at the 16 th Annual BIO CEO & Investor Conference on Monday, February 10 th at 9:30 am EST in the Conrad Room.
Sign-up for Agenus to Present at BIO CEO & Investor Conference investment picks
Agenus Inc. (Nasdaq: AGEN), a developer of therapeutic vaccines for cancer and infectious diseases, today announced that the company will be presenting at the 7 th Annual OneMedForum San Francisco 2014, which will be held at the Westin San Francisco Market Street in San Francisco.
Sign-up for Agenus to Present at OneMedForum San Francisco 2014 investment picks
2014/3/26
Agenus Inc. (Nasdaq: AGEN) today announced that Robert Stein, MD, PhD, Chief Scientific Officer of Agenus, will be presenting on Agenus’ checkpoint modulator portfolio and immuno-oncology strategy at the 4th Annual Cancer Immunotherapy Conference at the New York Academy of Medicine in New York City.
Sign-up for Agenus to Present at the 4th Annual Cancer Immunotherapy Conference investment picks
2013/9/4
Agenus Inc. (Nasdaq: AGEN) , a developer of therapeutic vaccines for cancer and infectious diseases, today announced that the company will present a corporate overview at two upcoming conferences.
Sign-up for Agenus to Present at Two Upcoming Healthcare Conferences investment picks
2014/2/27
Agenus Inc. (NASDAQ: AGEN) will release its fourth quarter and year end 2013 financial results before the market opens on March 5, 2014.
Sign-up for Agenus to Report Fourth Quarter and Year End 2013 Financial Results on March 5, 2014; Conference Call to Follow investment picks
2013/7/18
LEXINGTON, Mass., July 18, 2013 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN) will release its second quarter 2013 financial results before the market opens on July 25, 2013.
Sign-up for Agenus to Report Second Quarter 2013 Financial Results on July 25, 2013; Conference Call to Follow investment picks
Agenus Inc. (NASDAQ: AGEN) will release its third quarter 2013 financial results before the market opens on October 24, 2013.
Sign-up for Agenus to Report Third Quarter 2013 Financial Results on October 24, 2013; Conference Call to Follow investment picks
Agenus Inc. (Nasdaq:AGEN), a developer of therapeutic vaccines for cancer and infectious diseases, today announced that its Prophage Series (HSPPC-96) vaccine program for the treatment of brain cancer was selected as a 2013 Top Project to Watch in oncology.
Sign-up for Agenus’ Brain Cancer Vaccine Program Named a "Top Project to Watch" by Elsevier Business Intelligence investment picks
2013/11/7
Agenus Inc. (Nasdaq: AGEN), a developer of therapeutic vaccines for cancer and infectious diseases, today announced statistically significant top-line results from its Phase 2 randomized, double-blind, multi-center study for HerpV, a recombinant “off-the-shelf” therapeutic vaccine candidate for the treatment of patients with herpes simplex virus-2 (HSV-2). HerpV contains a defined mixture of peptides representing HSV-2 antigens plus Agenus’ QS-21 Stimulon ®* adjuvant.
Sign-up for Agenus’ HerpV Therapeutic Vaccine for Genital Herpes Meets Primary Endpoint in Randomized Phase 2 Trial investment picks
2014/1/21
Agenus Inc. (Nasdaq: AGEN), a biotechnology company developing novel immune system activating treatments for cancers and infectious diseases, announced that Phase 2 results of Prophage G-200 vaccine in recurrent patients with glioblastoma multiforme (GBM) were hailed as ‘exciting’ and a ‘very promising therapy’ in an editorial published in Neuro-Oncology , the leading journal of the Society of Neuro-Oncology.
Sign-up for Agenus’ Prophage Vaccine for Glioma Hailed As a ‘Very Promising Therapy’ in an Editorial Published in the Journal Neuro-Oncology investment picks
2013/11/5
Increasing Focus on Vehicle and Driver Safety, Security and Information Services for Automotive Manufacturers and Insurance Providers MEDFORD, Mass.
Sign-up for Agero, Inc. Completes Sale of its Connected Vehicle Services Division to SiriusXM Radio, Inc. investment picks
AGF and Instar Launch New Alternative Investment Offering for Institutional Investors Canada NewsWire Veteran infrastructure investment professional Gregory Smith to lead new joint venture company TORONTO , Jan.
Sign-up for AGF and Instar Launch New Alternative Investment Offering for Institutional Investors investment picks
2013/11/19
AGF and Primerica Renew Fund Relationship Agreement Canada NewsWire Primerica Concert Funds to Continue Investment in AGF Funds TORONTO , Nov.
Sign-up for AGF and Primerica Renew Fund Relationship Agreement investment picks
AGF Announces Changes to Fund Line Up Canada NewsWire AGF Investments Inc., announces two name changes and the termination of six funds.
Sign-up for AGF Announces Changes to Fund Line Up investment picks
2013/11/12
AGF Announces Changes to Portfolio Management Team and Product Lineup Canada NewsWire TORONTO , Nov.
Sign-up for AGF Announces Changes to Portfolio Management Team and Product Lineup investment picks
AGF Announces Changes to Product Lineup Canada NewsWire TORONTO , March 5, 2014 /CNW/ - AGF Investments Inc., (AGFI) today announced a series of changes designed to simplify and strengthen the product suite.
Sign-up for AGF Announces Changes to Product Lineup investment picks
AGF announces departure of Martin Hubbes Canada NewsWire TORONTO , Dec.
Sign-up for AGF announces departure of Martin Hubbes investment picks
2014/1/14
AGF Appoints Loblaw Executive Sarah Davis, CA to Board of Directors Canada NewsWire TORONTO , Jan.
Sign-up for AGF Appoints Loblaw Executive Sarah Davis, CA to Board of Directors investment picks
2014/1/31
AGF Management Limited - Normal Course Issuer Bid Canada NewsWire TORONTO , Jan.
Sign-up for AGF Management Limited - Normal Course Issuer Bid investment picks
2013/12/13
AGF Management Limited Declares Dividend Canada NewsWire TORONTO , Dec.
Sign-up for AGF Management Limited Declares Dividend investment picks
AGF Management Limited Declares Dividend Canada NewsWire TORONTO , Sept.
Sign-up for AGF Management Limited Declares Dividend investment picks
2014/3/26
AGF Management Limited Declares Dividend Canada NewsWire TORONTO , March 26, 2014 /CNW/ - On March 25, 2014 , the Board of Directors of AGF Management Limited declared a dividend of $0.27 per share on both the Class B Non-Voting shares and the Class A Voting common shares of the company.
Sign-up for AGF Management Limited Declares Dividend investment picks
2014/3/26
AGF Management Limited Reports First Quarter Financial Results Canada NewsWire Earnings per share from continuing operations up 17.6% TORONTO , March 26, 2014 /CNW/ - AGF Management Limited (AGF or the Company) today announced financial results for the first quarter ended February 28, 2014 , reporting diluted earnings per share (EPS) from continuing operations of $0.20 compared to $0.17 for the three months ended February 28, 2013 .
Sign-up for AGF Management Limited Reports First Quarter Financial Results investment picks
2014/1/29
AGF Management Limited Reports Fourth Quarter and Fiscal 2013 Financial Results Canada NewsWire Eleven consecutive months of improvement in retail business TORONTO , Jan.
Sign-up for AGF Management Limited Reports Fourth Quarter and Fiscal 2013 Financial Results investment picks
AGF Management Limited Reports Third Quarter Financial Results Canada NewsWire AGF reports earnings per share of $0.11 ; continued improvement in retail sales TORONTO , Sept.
Sign-up for AGF Management Limited Reports Third Quarter Financial Results investment picks
2014/3/17
AGF Management Limited To Release First Quarter Results On March 26, 2014 Canada NewsWire TORONTO , March 17, 2014 /CNW/ - AGF Management Limited (TSX: AGF.B) will release its financial results for the first quarter of fiscal 2014 on Wednesday, March 26, 2014 , at approximately 8 a.m. ET .
Sign-up for AGF Management Limited To Release First Quarter Results On March 26, 2014 investment picks
AGF Management Limited To Release Fiscal 2013 Results On January 29, 2014 Canada NewsWire TORONTO , Jan.
Sign-up for AGF Management Limited To Release Fiscal 2013 Results On January 29, 2014 investment picks
AGF Management Limited To Release Third Quarter Results On September 25, 2013 Canada NewsWire TORONTO , Sept.
Sign-up for AGF Management Limited To Release Third Quarter Results On September 25, 2013 investment picks
2013/12/3
AGF Offers New Funds on UCITS Platform Canada NewsWire Company also opens new London office to support growing roster of U.K. clients TORONTO , Dec.
Sign-up for AGF Offers New Funds on UCITS Platform investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Agenus to Participate in Brain Cancer Vaccine and Immunotherapy Discussion on September 23rd Webcast to AGF Offers New Funds on UCITS Platform
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity